The effects of various concentrations of ropivacaine on the onset and duration of ultrasound-guided ankle blocks in patients undergoing hallux valgus repair surgery – a randomized, double-blinded, parallel-group interventional study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-510569-41-00

Enrollment

126

Registered

2024-04-26

Start date

2025-05-22

Completion date

Unknown

Last updated

2024-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hallux valgus

Brief summary

The primary endpoint is the difference in the duration of the sensory blocks.

Detailed description

The difference in onset time of the sensory block., The difference in motor function., The difference in postoperative pain scores (analgesia)., The difference in opioid consumption.

Interventions

DRUGROPIVACAINE

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the difference in the duration of the sensory blocks.	—

Secondary

Measure	Time frame
The difference in onset time of the sensory block., The difference in motor function., The difference in postoperative pain scores (analgesia)., The difference in opioid consumption.	—

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026